Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
114173732 | 11417373 | 2 | F | 20150722 | 20160804 | 20150825 | 20160815 | EXP | GB-BAUSCH-BL-2015-019832 | BAUSCH AND LOMB | 67.00 | YR | F | Y | 58.50000 | KG | 20160815 | OT | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
114173732 | 11417373 | 1 | PS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | 40069 | ||||||||||
114173732 | 11417373 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | 40069 | ||||||||||
114173732 | 11417373 | 3 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | 40069 | 40 | MG | /wk | |||||||
114173732 | 11417373 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | 40069 | ||||||||||
114173732 | 11417373 | 5 | SS | POMALIDOMIDE | POMALIDOMIDE | 1 | Oral | Y | 0 | 4 | MG | QD | |||||||
114173732 | 11417373 | 6 | C | ALLOPURINOL. | ALLOPURINOL | 1 | 0 | 300 | MG | QD | |||||||||
114173732 | 11417373 | 7 | C | COTRIMOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | 0 | 960 | MG | TIW | |||||||||
114173732 | 11417373 | 8 | C | ENOXAPARIN | ENOXAPARIN | 1 | 0 | 40 | MG | QD | |||||||||
114173732 | 11417373 | 9 | C | LORON | 2 | Oral | 0 | 1040 | MG | QD | |||||||||
114173732 | 11417373 | 10 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 20 | MG | QD | ||||||||
114173732 | 11417373 | 11 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Oral | 0 | 1 | G | Q6H | ||||||||
114173732 | 11417373 | 12 | C | QUETIAPINE. | QUETIAPINE | 1 | Oral | 0 | 12.5 | MG | QD | ||||||||
114173732 | 11417373 | 13 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Oral | 0 | 200 | MG | QD | ||||||||
114173732 | 11417373 | 14 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 0 | 40 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
114173732 | 11417373 | 1 | Plasma cell myeloma |
114173732 | 11417373 | 5 | Plasma cell myeloma |
114173732 | 11417373 | 6 | Plasma cell myeloma |
114173732 | 11417373 | 7 | Prophylaxis |
114173732 | 11417373 | 8 | Prophylaxis |
114173732 | 11417373 | 9 | Product used for unknown indication |
114173732 | 11417373 | 10 | Product used for unknown indication |
114173732 | 11417373 | 11 | Product used for unknown indication |
114173732 | 11417373 | 12 | Product used for unknown indication |
114173732 | 11417373 | 13 | Product used for unknown indication |
114173732 | 11417373 | 14 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
114173732 | 11417373 | OT |
114173732 | 11417373 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
114173732 | 11417373 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
114173732 | 11417373 | 1 | 2009 | 0 | ||
114173732 | 11417373 | 2 | 201403 | 201406 | 0 | |
114173732 | 11417373 | 3 | 20150626 | 20150717 | 0 | |
114173732 | 11417373 | 4 | 201306 | 0 | ||
114173732 | 11417373 | 5 | 20150625 | 20150715 | 0 | |
114173732 | 11417373 | 6 | 20150626 | 20150723 | 0 | |
114173732 | 11417373 | 7 | 20150626 | 0 | ||
114173732 | 11417373 | 8 | 20150626 | 0 |